|
|
Volumn 10, Issue 1, 1995, Pages 23-28
|
|
Superiority of CA 125 over CA 19-9 and CEA for epithelial ovarian malignancies
|
|
Author keywords
CA 125; CA 19 9; carcinoma ovary; CEA; tumor markers
|
|
Indexed keywords
CA 125 ANTIGEN;
CA 19-9 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
TUMOR ANTIGEN;
TUMOR MARKER;
ARTICLE;
BLOOD LEVEL;
CANCER DIAGNOSIS;
CANCER RECURRENCE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
EPITHELIUM TUMOR;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
OVARY ADENOCARCINOMA;
OVARY CARCINOMA;
PROGNOSIS;
|
|
EID: 0029077005
PISSN: 09701915
EISSN: 09740422
Source Type: Journal
DOI: 10.1007/BF02873664 Document Type: Article |
|
Times cited : (4)
|
|
References (7)
|
